Maximum Observed Plasma Concentration (Cmax)
Showing 1 - 25 of >10,000
Maximum Observed Plasma Glucose Concentration (Cmax) Trial in Boston (Orange flavored beverage)
Completed
- Maximum Observed Plasma Glucose Concentration (Cmax)
- Orange flavored beverage
-
Boston, MassachusettsTufts University
Mar 8, 2021
Anesthesia Trial in Seoul (Remifentanil (Limited) - Target Controlled Infusion system, Remifentanil (Control) - Target
Not yet recruiting
- Anesthesia
- Remifentanil (Limited) - Target Controlled Infusion system
- Remifentanil (Control) - Target Controlled Infusion system
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 20, 2022
Hypertension, Heart Failure Trial in San Antonio (Prazosin HCl 2mg, Prazosin HCl 1 mg, Prazosin HCl 5 mg)
Completed
- Hypertension
- Heart Failure
- Prazosin HCl 2mg
- +2 more
-
San Antonio, TexasClinical Trials of Texas, LLC
Jul 6, 2022
Sickle Cell Disease Trial in San Antonio (Voxelotor, Bupropion, Repaglinide)
Recruiting
- Sickle Cell Disease
- Voxelotor
- +8 more
-
San Antonio, TexasICON Early Phase Services, LLC
Jul 31, 2023
Pharmacokinetics Trial in Burnaby (Quercetin LipoMicel (250 mg), Quercetin LipoMicel (500 mg), Quercetin LipoMicel (1000 mg))
Completed
- Pharmacokinetics
- Quercetin LipoMicel (250 mg)
- +3 more
-
Burnaby, British Columbia, CanadaISURA
Nov 3, 2022
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)
Not yet recruiting
- Relapsed Non-Hodgkin Lymphoma
- +6 more
- (no location specified)
Apr 12, 2023
Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)
Completed
- Ulcerative Colitis (UC)
- Crohn's Disease
- Risankizumab
- Cytochrome P450 (CYP) Substrates
-
Coronado, California
- +5 more
Oct 20, 2022
T2DM (Type 2 Diabetes) Trial in Beijing (HSK7653, Placebo)
Completed
- T2DM (Type 2 Diabetes Mellitus)
- HSK7653
- Placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 1, 2023
Healthy Volunteer Trial in Wuhan (GFH312 100 mg, GFH312 200 mg, GFH312 120mg)
Completed
- Healthy Volunteer
- GFH312 100 mg
- +3 more
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023
Healthy Trial in Madrid (Minoxidil Tablets, Minoxidil topical solution 20 mg/ml)
Not yet recruiting
- Healthy
- Minoxidil Tablets
- Minoxidil topical solution 20 mg/ml
-
Madrid, SpainHospital Universitario de la Princesa
Aug 25, 2023
Advanced Solid Tumor Trial in Australia, New Zealand, United States (BGB-A445, tislelizumab)
Recruiting
- Phase 1a:Advanced Solid Tumors; Phase 1b: Non-small Cell Lung Cancer (NSCLC) and Head and Neck Squamous Cell Carcinoma (HNSCC)
-
Pittsburgh, Pennsylvania
- +11 more
Aug 25, 2022
Healthy Volunteers Trial in Lenexa (BMS-986419, Caffeine, Bupropion)
Not yet recruiting
- Healthy Volunteers
- BMS-986419
- +6 more
-
Lenexa, KansasLocal Institution - 0001
Jun 27, 2023
Healthy Trial in New Haven (Zavegepant 10 mg IN)
Not yet recruiting
- Healthy
- Zavegepant 10 mg IN
-
New Haven, ConnecticutPfizer Clinical Research Unit - New Haven
Jul 7, 2023
Healthy Trial in New Haven (PF-07295324, PF-07259955)
Active, not recruiting
- Healthy
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Aug 3, 2022
ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)
Recruiting
- ccRCC
- +9 more
- Oral NKT2152
-
Scottsdale, Arizona
- +6 more
Oct 17, 2022